Treating obesity and heart failure: a how-to-manage guide from the European Association for the Study of obesity and the European Society of Hypertension working group on diabetes and metabolic risk factors
Authors:
- 10 March 2026
- journal article
- esh paper
- Published by Wolters Kluwer Health in Journal Of Hypertension
Abstract
Obesity is a key contributor to heart failure, driving increased morbidity, mortality, and healthcare costs. This association is supported by multiple pathophysiological mechanisms and consistent epidemiological evidence, particularly not only in heart failure with preserved ejection fraction (HFpEF), but also in heart failure with reduced ejection fraction (HFrEF). Given the rising prevalence of both diseases, integrated management strategies are essential. This review outlines current management options in patients with heart failure and obesity, from lifestyle modification to pharmacological and surgical treatment, and explores emerging treatments aimed at mitigating this growing burden.Keywords
This publication has 80 references indexed in Scilit:
- Comparative Efficacy of Metabolic/Bariatric Surgery Versus GLP ‐1 Receptor Agonists: A Network Meta‐Analysis of Randomized Controlled TrialsObesity, 2025
- Novel Controlled Metabolic Accelerator for Obesity-Related HFpEFJAMA Cardiology, 2025
- Intentional Weight Loss in Overweight and Obese Patients with Heart Failure: A Systematic ReviewEuropean Journal of Heart Failure, 2024
- Dietary Sodium and Fluid Intake in Heart Failure. A Clinical Consensus Statement of the Heart Failure Association of the ESCEuropean Journal of Heart Failure, 2024
- Body Mass Index and Cardiorenal Outcomes in the EMPEROR-Preserved Trial: Principal Findings and Meta-Analysis with the DELIVER TrialEuropean Journal of Heart Failure, 2024
- Weight Change and Clinical Outcomes in Heart Failure with Reduced Ejection Fraction: Insights from EMPEROR-ReducedEuropean Journal of Heart Failure, 2022
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureEuropean Journal of Heart Failure, 2022
- Efficacy of dapagliflozin in heart failure with reduced ejection fraction according to body mass indexEuropean Journal of Heart Failure, 2021
- Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection FractionJAMA, 2016
- Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection FractionJAMA, 2016